Open-label Adjunctive Zonisamide for Bipolar Disorder

Status

Terminated

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00047567

Enrollment

Registered

2002-10-10

Start date

2002-07-31

Completion date

2002-07-31

Last updated

2015-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorders

Keywords

ZONISAMIDE, BIPOLAR

Brief summary

To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.

Interventions

DRUGzonisamide

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Years to 17 Years

Healthy volunteers

Inclusion criteria

* Bipolar I/II * Average intelligence * Taking at least one, but no more than two mood stabilizers

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026